English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program
Jul 23, 2024 16:00 HKT
上市一年碩果紛呈 科倫博泰備戰商業化劍指Biopharma 估值躍升即將開啟
Jul 11, 2024 11:39 HKT
上市一年硕果纷呈 科伦博泰备战商业化剑指Biopharma 估值跃升即将开启
Jul 11, 2024 11:11 HKT
河套科创区携手13家创新企业 君圣泰医药助力创新药国际化发展
Jul 01, 2024 15:00 HKT
河套科創區攜手13家創新企業 君聖泰醫藥協助創新藥國際化發展
Jul 01, 2024 15:00 HKT
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801)
Jun 21, 2024 18:30 HKT
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate (HTD1801)
Jun 05, 2024 09:00 HKT
君圣泰医药将在2024年国际肝病大会发布MASH临床2a期研究分析结果,进一步展现熊去氧胆小檗碱(HTD1801)的疗效与安全性
Jun 05, 2024 09:00 HKT
君聖泰醫藥將在2024年國際肝病大會發布MASH臨床2a期研究分析結果,進一步展現熊去氧膽小檁鹼(HTD1801)的療效與安全性
Jun 05, 2024 09:00 HKT
BIO24에서 발표된 새로운 연구에서 내부 규제 사항을 갖춘 CRO는 생명공학 기업에게 30%의 절감을 제공하고, 시간을 절반으로 줄이며, 위험을 줄입니다
Jun 04, 2024 22:56 HKT
新研究發現,具有內部監管事務的CRO公司為生物技術公司節省30%的成本,縮短時間線一半,降低風險
Jun 04, 2024 22:46 HKT
新研究发现,具有内部监管事务的CRO公司为生物技术公司节省30%的成本,缩短时间线一半,降低风险
Jun 04, 2024 22:25 HKT
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs
Jun 04, 2024 22:00 HKT
Avance Clinical通过与Julius Clinical合作,在欧洲扩展专门的中枢神经系统、心血管代谢和罕见疾病的CRO服务
Jun 01, 2024 06:00 HKT
Avance Clinical透過與Julius Clinical合作,在歐洲擴展專門的中樞神經系統、心血管代謝和罕見疾病的CRO服務
Jun 01, 2024 06:00 HKT
Avance Clinical, Julius Clinical과 함께 유럽에서 중추신경계(CNS), 심장대사 및 희귀 질환 전문 CRO 서비스를 확장하다
Jun 01, 2024 06:00 HKT
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical
May 31, 2024 16:00 HKT
Avance Clinical, 한국에서 새로운 임상 운영으로 APAC 지역으로 더 확장
May 09, 2024 08:00 HKT
Avance Clinical 在亞太地區進一步擴張,韓國新的臨床運營
May 09, 2024 07:55 HKT
Avance Clinical 在亚太地区进一步扩张,韩国新的临床运营
May 09, 2024 07:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: